Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor
Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor
Enrolling by invitation · NCT07065357 · Registry updated 2025-08-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor | Insulin Resistance, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperinsulinism, metabolic disease | Enrolling by invitation | Phase 3 | 2025-08-24 | NCT07065357 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Hong Kong | 349 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Queen Mary Hospital | Hong Kong | Hong Kong | 96 |